A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.

Subjects

Subjects :

Antineoplastic Combined Chemotherapy Protocols therapeutic use
Chemotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Combined Modality Therapy
Humans
Interleukin-2 therapeutic use
Pleura surgery
Radiotherapy, Adjuvant
Research Design
Mesothelioma therapy
Pleural Neoplasms therapy

Details

Language :

English

ISSN :

1010-7940

Volume :

31

Issue :

3

Database :

MEDLINE

Journal :

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Publication Type :

Editorial & Opinion

Accession number :

17267238

Full Text :

https://doi.org/10.1016/j.ejcts.2007.01.011